Stonepine Capital Management as of Dec. 31, 2015
Portfolio Holdings for Stonepine Capital Management
Stonepine Capital Management holds 13 positions in its portfolio as reported in the December 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Vanda Pharmaceuticals (VNDA) | 20.9 | $18M | 1.9M | 9.31 | |
| Cti Biopharma | 15.4 | $13M | 11M | 1.23 | |
| SciClone Pharmaceuticals | 12.7 | $11M | 1.2M | 9.20 | |
| Tobira Therapeutics Inc Common Stock Usd 0.0001 | 9.8 | $8.4M | 833k | 10.05 | |
| Sagent Pharmaceuticals | 8.6 | $7.4M | 463k | 15.91 | |
| Pernix Therapeutics Holdings | 8.6 | $7.3M | 2.5M | 2.95 | |
| Pain Therapeutics | 7.3 | $6.3M | 3.6M | 1.75 | |
| Foundation Medicine | 4.3 | $3.6M | 173k | 21.06 | |
| Vericel (VCEL) | 4.2 | $3.6M | 1.4M | 2.58 | |
| Enanta Pharmaceuticals (ENTA) | 2.8 | $2.3M | 71k | 33.02 | |
| Derma Sciences | 2.7 | $2.3M | 508k | 4.57 | |
| Cutera | 1.5 | $1.3M | 100k | 12.79 | |
| Recro Pharma | 1.2 | $1.1M | 117k | 9.00 |
